Delivery Order SPE2DB22D3102-SPE2DB25FL2WK
- Not listed
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin Phosphate 1% Lotion in 60ml quantities, with a ceiling value of $3,766.03. This competitive award, issued with firm fixed pricing and no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.16 for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.42 firm fixed-price contract is for the delivery of 4567445128 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.80 to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ml quantities. This contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was...
- The Defense Logistics Agency awarded a $499.93 delivery order contract to Amerisourcebergen Drug Corporation to supply 100mL of 75mg/5mL clindamycin pediatric liquid. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania by July 24, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's Corporate Office Division contract vehicle with the Defense Logistics Agency. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,170.09 firm fixed-price delivery order is for the supply of 4566322557 - Clindamycin (Pedi) 75 mg/5 ml 100 ml. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2WKDelivery Order
The Defense Logistics Agency awarded a $1,480.32 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide. The contract supports multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, as part of DLA's broader strategy to maintain robust pharmaceutical support capabilities across government operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/8/25 |